Lead Product(s) : Adefovir
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : GSK
Deal Size : Inapplicable
Deal Type : Inapplicable
Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 07, 2012
Lead Product(s) : Adefovir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : GSK
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
